Literature DB >> 34052941

Molecular Diversity of Aspergilli in Two Iranian Hospitals.

Mohammad Javad Najafzadeh1, Somayeh Dolatabadi2, Hossein Zarrinfar3, Jos Houbraken4.   

Abstract

The Aspergillus species are main causative agents of various infections such as invasive aspergillosis (IA) in immunocompromised patients and these infections have high mortality rates. In this study, we provide insight in the species causing aspergillosis in Iran based on morphology and sequence data. Clinical (n = 117) and environmental isolates (n = 54) collected during 2010-2016 from University hospitals in Mashhad and Tehran (Iran) were identified both morphologically and molecularly using partial calmodulin (CaM) gene sequences. Clinical cases were identified based on EORTC/MSG criteria. Aspergillus flavus (n = 96, 55%) was the most prevalent species among the clinical and environmental isolates while A. fumigatus (n = 13, 7.5%) ranked fourth after A. tubingensis (n = 23, 13%) and A. welwitchiae (n = 18, 10%). Species such as A. tubingensis, A. welwitschiae, A. fumigatus, A. sydowii, A. neoniger and A. terreus were present in both clinical and environmental samples indicating the possible environmental source of infections. Interestingly, A. niger was isolated only once. Furthermore, 13 other rare and cryptic Aspergillus species were detected. Pulmonary and respiratory disorders (n = 33), followed by transplantation (n = 23), invasive fungal rhinosinusitis (n = 14), and haematological malignancies (n = 12) were major predisposing factors. According to EORTC/MSG criteria, there were 43 probable cases identified followed by 36 cases for each of proven and possible ones. Correct molecular identification will be useful for further epidemiological studies.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  A. tubingensis; A. welwitschiae; Calmodulin sequencing

Year:  2021        PMID: 34052941     DOI: 10.1007/s11046-021-00563-z

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  54 in total

1.  Factors associated with mortality in transplant patients with invasive aspergillosis.

Authors:  John W Baddley; David R Andes; Kieren A Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; Thomas J Walsh; Mindy G Schuster; John R Wingard; Thomas F Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

Review 2.  Invasive aspergillosis in glucocorticoid-treated patients.

Authors:  Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Med Mycol       Date:  2008-07-24       Impact factor: 4.076

3.  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Authors:  D Neofytos; S Treadway; D Ostrander; C D Alonso; K L Dierberg; V Nussenblatt; C M Durand; C B Thompson; K A Marr
Journal:  Transpl Infect Dis       Date:  2013-02-21       Impact factor: 2.228

4.  Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma.

Authors:  N L Smith; D W Denning
Journal:  Eur Respir J       Date:  2010-07-01       Impact factor: 16.671

5.  Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature.

Authors:  P C Iwen; M E Rupp; S H Hinrichs
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

6.  Allergic fungal sinusitis: CT findings.

Authors:  S K Mukherji; R E Figueroa; L E Ginsberg; B A Zeifer; B F Marple; J G Alley; L L Cooper; W R Nemzek; D M Yousem; K R Jones; S B Kupferberg; M Castillo
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

7.  The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Authors:  J R Perfect; G M Cox; J Y Lee; C A Kauffman; L de Repentigny; S W Chapman; V A Morrison; P Pappas; J W Hiemenz; D A Stevens
Journal:  Clin Infect Dis       Date:  2001-10-22       Impact factor: 9.079

8.  Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.

Authors:  J E Patterson; J Peters; J H Calhoon; S Levine; A Anzueto; H Al-Abdely; R Sanchez; T F Patterson; M Rech; J H Jorgensen; M G Rinaldi; E Sako; S Johnson; V Speeg; G A Halff; J K Trinkle
Journal:  Transpl Infect Dis       Date:  2000-03       Impact factor: 2.228

9.  Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review.

Authors:  David W Denning; Kostantinos Riniotis; Richard Dobrashian; Helen Sambatakou
Journal:  Clin Infect Dis       Date:  2003-10-01       Impact factor: 9.079

10.  Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals.

Authors:  S Hussain; N Salahuddin; I Ahmad; I Salahuddin; R Jooma
Journal:  Eur J Radiol       Date:  1995-07       Impact factor: 3.528

View more
  1 in total

1.  Recombinant polymerase amplification combined with lateral flow strips for the detection of deep-seated Candida krusei infections.

Authors:  Mengdi Zhao; Xizhen Wang; Kun Wang; Yuanyuan Li; Yan Wang; Ping Zhou; Lei Wang; Wenjun Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-29       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.